Imidapril
{{Drugbox | verifiedrevid = 444377257 | IUPAC_name = (4S)-3-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid | image = Imidapril structure.png
| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =
| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =
| CAS_number_Ref = 
| CAS_number = 89371-37-9
| ATC_prefix = C09
| ATC_suffix = AA16
| ATC_supplemental =
| PubChem = 5464343
| DrugBank_Ref =
| DrugBank =
| UNII_Ref =
| UNII = BW7H1TJS22
| KEGG_Ref =
| KEGG = D08068
| chemical_formula = | C=20 | H=27 | N=3 | O=6 | molecular_weight = 405.444 g/mol }}
Imidapril (INN) is an ACE inhibitor used as an antihypertensive drug and for the treatment of chronic heart failure.[1]
References
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |